Drug Profile
NEOSH 101
Alternative Names: NEOSH101Latest Information Update: 21 Jul 2011
Price :
$50
*
At a glance
- Originator Neosil
- Class Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alopecia
Most Recent Events
- 21 Jul 2011 Discontinued - Phase-II for Alopecia in Germany (Topical)
- 12 Nov 2009 Peplin has been acquired by LEO Pharma
- 20 Oct 2008 Neosil has been acquired by Peplin